ICU Medical (NASDAQ: ICUI) has introduced a new 25% threshold for shareholders to call special meetings, a move analysts say could either streamline governance or concentrate power. The change comes amid increasing scrutiny of corporate governance structures in the healthcare sector.
The company, which specializes in infusion therapy and critical care products, amended its bylaws last week to allow shareholders owning at least 25% of outstanding shares to request special meetings. Previously, no such provision existed. Governance experts are divided on whether this represents progress or creates new risks.
‘This threshold is more restrictive than the 10-15% standards at many peer companies,’ noted a corporate governance analyst at a major investment firm who asked not to be named. ‘While it does create a mechanism for shareholder action, the high bar could effectively prevent meaningful challenges to management.’
ICU Medical’s stock has underperformed the S&P 500 healthcare equipment index by 12% over the past year. Some investors have privately expressed concerns about the company’s growth strategy and acquisition track record. The new governance provision may be seen as an attempt to address these concerns while maintaining board control.
Looking ahead, proxy advisory firms are expected to weigh in on the change ahead of next year’s annual meeting. The move could become a test case for how institutional investors balance governance principles with practical considerations in mid-cap healthcare companies.